Benvenue Medical's Luna 360 Interbody Fusion System received 510(k) clearance from the U.S. Food and Drug Administration for spinal fusion treatment of symptomatic degenerative disc disease.
The Luna 360 System is a minimally invasive lumbar interbody fusion device for degenerative disc disease that provides spine surgeons a small delivery cannula for posterior access, which expands to a large footprint. It is made from PEEK-OPTIMA a biocompatible polymer.
"The Luna 360 expandable implant brings the benefits of ALIF surgery and cage size with a controlled and guided TLIF delivery and addresses many of the deficiencies of current expandable interbody fusion devices," said Sandeep Kunwar, MD, neurosurgeon at the Fremont-based California Center for Minimally Invasive Brain & Spine Surgery and associate professor of neurological surgery at the University of California San Francisco. "This minimally invasive approach enables us to stabilize the spine and restore the native anatomy."
More articles on devices:
Will Aurora Spine continue growth? 10 key notes from 3Q
5 quick facts on US Medical Innovations' distribution agreement with CrossLink Surgical
10 things to know about Medtronic's $17B bond sale